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Abstract
Objective: The ®eld of tissue engineering deals with the creation of tissue structures based on patient cells. The scaffold plays a central
role in the creation of 3-D structures in cardiovascular tissue engineering like small vessels or heart valve prosthesis. An ideal scaffold should
have tissue-like mechanical properties and a complete immunologic integrity. As an alternative scaffold the use of ®brin gel was investigated.
Methods: Preliminary, the degradation of the ®brin gel was controlled by the supplementation of aprotinin to the culture medium. To prevent
tissue from shrinking a mechanical ®xation of the gel with 3-D microstructure culture plates and a chemical ®xation with poly-l-lysine in
different ®xation techniques were studied. The thickness of the gel layer was changed from 1 to 3 mm. The tissue development was analysed
by light, transmission and scanning electron microscopy. Collagen production was detected by the measurement of hydroxyproline. Injection
molding techniques were designed for the formation of complex 3-D tissue structures. Results: The best tissue development was observed at
an aprotinin concentration of 20 mg per cc culture medium. The chemical border ®xation of the gel by poly-l-lysine showed the best tissue
development. Up to a thickness of 3 mm no nutrition problems were observed in the light and transmission electron microscopy. The molding
of a simpli®ed valve conduit was possible by the newly developed molding technique. Conclusion: Fibrin gel combines a number of
important properties of an ideal scaffold. It can be produced as a complete autologous scaffold. It is moldable and degradation is controllable
by the use of aprotinin. q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The ®eld of tissue engineering provides an alternative to
organ and tissue transplants based on the limited supply of
donor organs. Isolated cells are commonly used to engineer
new tissues. The cells will be seeded on a three dimensional
scaffold followed by in vitro culturing. In a second step the
newly formed structure will be seeded with autologous
endothelial cells to create a viable, active surface with
high biocompatibility.
The scaffolds serve as physical supports and templates for
cell attachment and tissue development. With the principles
of tissue engineering, the creation of new tissues in cardio-
vascular surgery will be realized, such as heart valves,
cardiac muscles, pericardium, and vessels [1±3].
The requirements for an ideal scaffold are the easy hand-
ling and molding of complex 3-D structures like valve
conduits or vessels with complex side branches. The mate-
rial should not be toxic or have any immunologic side
effects. The diffusion barrier of the scaffold has to be as
low as possible to guarantee an optimal nutrition in thicker
tissues. The mechanical as well as the chemical properties
(e.g. the integration of growth factors) should be modi®-
able. The control of the degradation is important to adapt
the structural support of the scaffold to the tissue develop-
ment.
Many substances are used in the production of scaffolds,
e.g. synthetic polymers (polyurethanes (PUR), polyglyolic
acid (PGA), polylactic acid (PLA), polyhydroxybutyrate
(PH4B), copolymers of lactic and glycolic acids, polyanhy-
drides, polyortho esters) and natural polymers (chitosan,
glycosaminoglycans, collagen) or biological scaffolds like
acellularized porcine aortic conduits [4±7]. Scaffold-related
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problems like cytotoxic degradation products, ®xed degra-
dation times, limited mechanical properties and the absence
of a growth modulation etc. make further extensive inves-
tigations on the ideal scaffold necessary.
The creation of complex 3-D cardiovascular structures is
the aim of our investigations. With the conventionally used
scaffolds the formation of different layer thickness is proble-
matic and depends on the production limit of the scaffold
thickness. The connection of the different components like
the cusps with the vascular wall is also problematic. The
production of the complete structure in one part with a
biodegradable polymer in an injection molding technique
will solve several important problems.
Fibrin gel as such is a biodegradable polymer. It can be
produced from the patients own blood and used as an auto-
logous scaffold for the seeded ®broblasts without the poten-
tial risk of a foreign body reaction. The use of ®brin gel as an
ªidealº scaffold for cardiovascular tissue engineering was
investigated in our research group:
The following characterization of the ®brin gel was
necessary to de®ne the boundary conditions for a molding
technique.
1. The degradation of the gel takes place within a few days
by the plasminogen in the culture medium. Successful
degradation control will make the use of ®brin gel possi-
ble. As reported previously, the best tissue development
was observed by a degradation control with 20 mg/ml
aprotinin supplemented to the medium [8].
2. In the injection molding technique the vascular wall and
the cusp is formed by the same scaffold. The construction
of thicker structures is limited, because the exchange of
the nutriments in the tissue engineered structures without
vasa vasorum can only take place by diffusion. On this
account, the tissue development initially depends on the
diffusion resistance of the tissue/scaffold in terms of a
good nutritional supply and removal of the metabolic
substances.
3. The phenomenon of tissue shrinking is a product of struc-
tural changes in the scaffold and the contraction of the
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Fig. 1. Biochemical vs. mechanical method of gel ®xation: the biochemical ®xation was investigated in two different ®xation techniques, bottom vs. border
®xation (left). The mechanical ®xation was realized by a 3-D microstructured Tissue Culture Polysterene Plate (3-D TCPS) (Integra Bioscience Inc.,
Switzerland) (right).
new synthesized collagen bundles. The prevention of
tissue shrinking is essentially to get functional tissues.
4. The molding technique itself is complex and in this study
the following questions were evaluated in a simpli®ed
model of a valve conduit: (1) mix technique regarding
to the limited polymerization time of the gel, (2) gel
adherence to the mold, and the (3) feasibility of molding
complex structures with a different layer thickness in the
vascular and the cusps part.
2. Material and methods
2.1. The production of viable cardiovascular structures
bases on an suspension of myo®broblasts and the ®brin gel
2.1.1. Cell culturing
Mixed cell cultures were obtained from human ascending
aorta of explanted hearts. The myo®broblast cells were
cultured in the `basic medium', which consists of Dulbec-
co's modi®ed Eagle's medium supplemented with 10% fetal
bovine serum and 1% antibiotic-antimycotic solution
(Gibco BRL-Life Technologies, Grand Island, NY). To
obtain suf®cient cell numbers, cells were serially passaged
three to four times.
2.1.2. Fibrin gel production
Fibrinogen from human plasma being plasminogen free
(Fluka Inc.) was dissolved in water and dialysed with a
cutoff membrane of 6-8.-000 MW overnight against Tris
buffered saline. The ®brinogen solution was serial ®ltered
and sterilized. 10 % 50 mM CaCl2, 20% Thrombin (20 units/
ml) and 70% resuspended cells in Tris buffered saline were
mixed gently. The ®brinogen was added in a ratio 1:1 and
mixed by gently shaking.
The tissue was cultured with `basic medium' supplemen-
ted with 1 mM l-ascorbic acid 2-phosphate to increase the
collagen production [9].
A degradation control of the scaffold is desirable to adapt
the scaffold degradation to the tissue development, this
degradation of the gel was controlled by the supplementa-
tion of aprotinin (20 mg/ml medium) [8].
2.2. Variation of the layer thickness
The thickness of the gel layer was varied from 1 to 3 mm
with 1 mm steps (n  4 per group). All gels were ®xed by a
border ®xation with a 0.01% poly-l-lysine solution as
described below.
Prevention of tissue shrinking was investigated by differ-
ent ®xation methods. Furthermore the ®xation of the gel on
the one hand and the tendency of shrinking on the other
hand might lead to a positive mechanical stress in the tissue,
which might induce the collagen production and thereby the
mechanical properties of the tissue. For this reason a
complete bottom ®xation (n  4) was different from a
small border ®xation (2 mm) (n  4) to investigate the in¯u-
ence on the tissue development in the biochemical ®xation
method (see Fig. 1, left side).
The biochemical ®xation were realized with a 0.01%
solution of poly-l-lysine. The poly-l-lysine were air dried
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Fig. 2. Mold for the formation of a simpli®ed aortic root: the outer cylinder is coated by a variable silicon layer. The inner part of the conduit will be formed by
the ªaorticº and the ªventricularisº stamp. The distance between the stamps is variable.
and afterwards washed with phosphate buffered saline.
Wells without coating were used as a control (n  4).
The cytotoxic side-effects of poly-l-lysine in higher
concentrations is known. As an alternative, a mechanical
®xation was investigated with a new available 3-D micro-
structured Tissue Culture Polystyrol Plate (3-D TCPS)
(Integra Bioscience Inc., Switzerland) (n  12). The
squared 3-D structure of the plate was used to ®x the gel
in the primary position (see Fig. 1, right side). Biochemical
border ®xed ®bringel was used as a control (n  6).
2.3. Molding technique
A molding technique was generated for the creation of a
simpli®ed valve conduit. To test the feasibility of such a
molding technique, simpli®ed aluminum `ventricular' and
`aortic' stamps were formed and coated with a thin silicone
layer. The distance between the two parts is adjustable to get
different cusp thickness. The mold is circumferentially
limited by a silicone coated aluminum cylinder (Fig. 2).
The cell suspension of myo®broblasts in Tris saline solution
supplemented with calcium and thrombin was ®lled in the
mold with the `aortic' stamp in a water bath at 378C. The
polymerization of the ®brin gel was started in the mold after
the supplementation of ®brinogen. Within a few seconds the
`ventricularis' stamp was ®t in the mold along the guide rail
and moved gently to eliminate air bubbles. After an incuba-
tion time of 1 h the cast was carefully removed.
The tissue development was investigated histologically
and biochemically regarding the collagen production. For
the histological evaluation specimens were ®xed in 4%
formalin and stained by haematoxylin and eosin as well as
Masson's trichrome. Transmission electron microscopy
specimens were ®xed with Na-Cacodylat-buffered glutaral-
dehyde (2.5%) and paraformaldehyde (0.8%), and were
post-®xed with 1% osmium tetroxide, dehydrated in a series
of alcohol, and embedded. Ultra-thin sections were stained
with uranyl acetate and lead citrate. The specimens were
investigated under light microscopy and transmission elec-
tron microscopy.
The hydroxyproline assay was performed as a marker of
the collagen production and the tissue development to the
method of Reddy et al. [10].
2.4. Statistics
The data are expressed as mean ^ SD of the mean.
Student's t-test was used to assess the modifying effect of
the different ®xation methods and the threshold for statisti-
cal signi®cance was set at P , 0:05.
3. Results
Fig. 3 demonstrates the simpli®ed valve conduit based on
the newly developed molding technique. The tissue was
easily peeled off the mold and the silicon coated `ventricu-
laris' and `aortic' stamp could also be pulled out easily.
After the retraction of the gel, the thickness of the vascular
wall was circa 2 mm and the layer thickness of the cusps was
around 0.5 mm. The tissue was sutureable, but the initial
stiffness of the gel construction was too low for a direct
implantation.
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Fig. 3. Model of a valve conduit based on a molded ®brin gel scaffold.
Fig. 4. Fibrin gel after a culturing period of 4 weeks with well developed
extracellular matrix and organized collagen bundles (arrow).
The microscopic evaluation of the gels showed an homo-
genous cell distribution. No cell necrosis in the light micro-
scopic and transmission electron microscopic evaluations
was observed up to a layer thickness of 3 mm. Fig. 4
shows the transmission electron microscopic picture of
®brin gel tissue after a culturing period of 4 weeks. The
tissue consists of viable cells surrounded by a well devel-
oped extracellular matrix with organized collagen bundles.
The prevention from shrinking in the mechanical ®xed
group showed two of 12 partial and four of 12 complete
tissue detachments vs. no detachment in the poly-l-lysine
border ®xed control group (Fig. 1, right side). The concen-
tration of hydroxyproline was signi®cantly higher
(P , 0:05) in poly-l-lysine ®xed group (7.1 mg/
mg ^ 1.78) than in the non-detached mechanical ®xed
group (4.8 mg/mg ^ 0.6) (Fig. 5).
The control group showed a shrinking to a size less than
30% of the initial seeded area in the biochemical ®xation
tests with poly-l-lysine (Fig. 1, left side). No shrinking was
observed in the bottom or border ®xed group. After a cultur-
ing period of 50 days the highest concentration of hydro-
xyproline was detected in the border ®xed group (5.78 mg/
mg ^ 0.02) signi®cantly (P , 0:05) different to the non
(3.75 mg/mg ^ 0.63) and the bottom (4.58 mg/mg ^ 0.26)
®xed group (Fig. 6).
4. Discussion
The aim of the study was the evaluation of ®brin gel as a
scaffold for the production of 3-D cardiovascular structures
like vessels or valve conduits. The tissue development in the
gel showed excellent results up to a layer thickness of 3 mm.
And therefore the formation of a complex structure with a
different thickness in the vascular and the cusp part was
successfully simulated in the simpli®ed mold model.
In comparison to the most commonly used scaffolds,
®brin gel combines some important advantages. At ®rst,
the degradation of the scaffold is controllable and can be
adapted to the tissue development. Fibrin as a natural poly-
mer will be formed by the enzymatic polymerization of
®brinogen. We pro®t of the degradation and remodelling
by cell-associated enzymatic activity and the regulation of
this process by aprotinin, a protease inhibitor, which is able
to stop the ®brinolysis via inhibiting plasmin completely or
slow down the degradation of the gel in vitro.
Beyond it, ®brin gel can be produced from patients blood
and therefore the risk of immunogenic reactions are improb-
able. The potential risks of, e.g. virus infections by the use
of scaffolds based on homo- or xenografts are non-existent.
The cell distribution in the scaffold is an important factor
for a strong tissue development. It is known, that the initi-
ally high homogenous cell distribution is associated with
high rates of extracellular matrix production [11±13].
The distribution and attachment of cells in sponge struc-
tures (collagen, PUR sponges etc.) or ®ber structures
(PGA, PH4B etc.) are mainly determined by gravity [14].
Although the cell attachment of ®ber structures can be
improved by different precoating techniques, circa 30±
40% of the initially seeded cells do not attach to the scaf-
fold and get lost for a further tissue development [15,16].
The spatially uniform distribution is a function of the
porosity and surface charge of the scaffold. In sponge scaf-
folds the highest concentration of the cells is observed on
the surface of the tissue [17,18] and the cell migration into
the scaffold take place afterwards. This results in a delayed
tissue development.
In contrast, the distribution in the ®brin gel is homoge-
nous from the beginning, caused by the fast immobilization
of the cells during the polymerization of the gel/cell suspen-
sion within a few minutes.
Copolymers of lactic and glycolic acid especially PGA
have the major disadvantage of a bulk degradation. We
observed local, central cell necrosis in thicker PGA scaf-
folds after culturing period of 4 to 5 weeks, when the pH in
the medium falls rapidly to low values by the degradation
product lactic acid. Such phenomenon were not observed in
the ®brin gel degradation and structures with a layer thick-
ness up to 3 mm can be produced trouble-free.
The ®brin gel seems to be able to accumulate the newly
synthesized collagen and other extracellular matrix compo-
nents in the intercellular space. The diffusion and wash-out
of this substances into the surrounding medium seems to be
S. Jockenhoevel et al. / European Journal of Cardio-thoracic Surgery 19 (2001) 424±430428
Fig. 5. Hydroxyproline concentration regard to the ®xation method:
mechanical ®xation with a 3-D TCPS vs. biochemical border ®xation
with poly-l-lysine.
Fig. 6. Hydroxyproline concentration regard to the ®xation method after a
culturing period of 50 days.
reduced in the ®brin gel as a solid scaffold in comparison to
porous matrices.
In vitro studies showed that ®brin gels produced from
patients blood promote the matrix synthesis through the
release of platelet-derived growth factors and the transform-
ing growth factor beta [19].
The possibility to cross-link exogenous bifunctional
peptides into ®brin gels with factor XIIIa allows the immo-
bilization of different growth factors in speci®c areas of the
engineered structure. Through this, the immobilization of,
e.g. vascular growth factors in the aortic wall can promote
the development of vasa vasorum locally and allows the
construction of thicker tissues [20±23].
Fibrin gel as an ideal scaffold has two major disadvan-
tages: The shrinking of the gel and the initial, low mechan-
ical stiffness, which do not allow a direct implantation of the
new formed structures.
Shrinking is a problem in the formation of ¯at sheets for
the production of tissue engineered single cusps or percar-
dium. The problem can be solved by the ®xation of the gel
with poly-l-lysine during the culturing period. The techni-
que of a border ®xation obtains the best results relating to
the collagen synthesis and tissue development. The inner
tension in the gel as a product of the tendency of shrinking
and the ®xation seems to be a promoter of the collagen
synthesis. Culturing under de®ned shear stress can increase
the collagen synthesis additionally [24].
The low initial stability is the topic of our current inves-
tigations. The optimization of the ®brinogen concentration
in relation to the cell concentration in the gel promise an
increase of the mechanical properties. Another alternative is
the combination of high porous biodegradable scaffolds
(pore size .1 mm) with the ®brin gel as a cell carrier.
In conclusion, ®brin gel combines a number of important
properties of an ideal scaffold. It can be produced as an
complete autologous scaffold. The degradation is controlla-
ble and can be adjusted to the tissue development by the use
of aprotinin and the integration of growth factors is possible.
The formation of complex 3-D structures (e.g. aortic
conduits) seems to be possible.
Further investigation has to be undertaken to improve the
initial mechanical stability. In addition the development of a
mold for the creation of a tricuspid valve conduit as well as
the construction of a pulsatile bioreactor are the further
topics for a successful heart valve development based on a
®brin gel scaffold.
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